Merck’s Q1 figures have to be carefully read. Group sales rose +5% (organic: +3%) to €3,861m and the gross profit margin clearly improved from 64.3% to 66.4%. By contrast, EBITDA weakened 6% to €1,203m and net income attributable to shareholders dropped 12% to €523m. Operating CF more than doubled (€777m after €352m), based on the strong organic development and additionally fuelled by lower NWC outflows (€-182m after €-266m). The current year’s N
18 May 2017
Profitability burdened by multiple factors
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Profitability burdened by multiple factors
Merck KGaA (MRCK:WBO) | 0 0 1.2% | Mkt Cap: 10,792m
- Published:
18 May 2017 -
Author:
Martin Schnee -
Pages:
3
Merck’s Q1 figures have to be carefully read. Group sales rose +5% (organic: +3%) to €3,861m and the gross profit margin clearly improved from 64.3% to 66.4%. By contrast, EBITDA weakened 6% to €1,203m and net income attributable to shareholders dropped 12% to €523m. Operating CF more than doubled (€777m after €352m), based on the strong organic development and additionally fuelled by lower NWC outflows (€-182m after €-266m). The current year’s N